Genetic variants related to successful migraine prophylaxis with verapamil

Genetic variants related to successful migraine prophylaxis with verapamil

Abstract Background Currently, there is no biologically based rationale for drug selection in migraine prophylactic treatment. Methods To investigate the genetic variation underlying treatment response to verapamil prophylaxis, we selected 225 patients from a longitudinally established, deeply pheno...

Full description

Bibliographic Details
Main Authors: Fred Michael Cutrer, Ann M. Moyer, Elizabeth J. Atkinson, Liguo Wang, Shulan Tian, Yanhong Wu, Ivan Garza, Carrie E. Robertson, Carey A. Huebert, Brenda E. Moore, Christopher J. Klein
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
genomic
migraine
phospholipase‐C
prophylactic
verapamil
Online Access:https://doi.org/10.1002/mgg3.1680

Similar Items

Similar Items